Cunha, P.; Ribeiro, R.; Pizarro, A.; Mota, J.; Ribeiro, J.C.
The Role of Daily Activity in Risk and Survival Outcomes for Chronic Lymphocytic Leukemia Patients: Baseline Insights from the ADRENALINE Pilot Study. Lymphatics 2025, 3, 45.
https://doi.org/10.3390/lymphatics3040045
AMA Style
Cunha P, Ribeiro R, Pizarro A, Mota J, Ribeiro JC.
The Role of Daily Activity in Risk and Survival Outcomes for Chronic Lymphocytic Leukemia Patients: Baseline Insights from the ADRENALINE Pilot Study. Lymphatics. 2025; 3(4):45.
https://doi.org/10.3390/lymphatics3040045
Chicago/Turabian Style
Cunha, Pedro, Ricardo Ribeiro, Andreia Pizarro, Jorge Mota, and José Carlos Ribeiro.
2025. "The Role of Daily Activity in Risk and Survival Outcomes for Chronic Lymphocytic Leukemia Patients: Baseline Insights from the ADRENALINE Pilot Study" Lymphatics 3, no. 4: 45.
https://doi.org/10.3390/lymphatics3040045
APA Style
Cunha, P., Ribeiro, R., Pizarro, A., Mota, J., & Ribeiro, J. C.
(2025). The Role of Daily Activity in Risk and Survival Outcomes for Chronic Lymphocytic Leukemia Patients: Baseline Insights from the ADRENALINE Pilot Study. Lymphatics, 3(4), 45.
https://doi.org/10.3390/lymphatics3040045